HIV
New study shows that HCQ increases chance of death in COVID-19 patients. Additionally, research shows promising hope for a new HIV drug. Should acetaminophen be used more frequently for sports injuries?
This month, more than 50 patients have filed lawsuits against the California-based drug company, alleging that Gilead Sciences has prioritized financial gains over safety as its human immunodeficiency virus (HIV) antiretroviral drugs have led to chronic kidney diseases and major bone fractures. Per the San Mateo Daily Journal (Foster City,…
The PrEP regimen, which relies on taking the combination antiretroviral pill Truvada, can help prevent HIV. Here’s what you should know about it. For decades, abstinence and condoms were the only options for preventing HIV. Today, there’s a third: Truvada, a combination pill comprising 2 antiretroviral medications (emtricitabine and tenofovir)…
Genvoya, a new anti-HIV drug that could drastically reduce long-term side effects, was given European Commission approval, allowing 28 countries in the EU to give it to HIV-positive patients. Trials show that Genvoya leads to reduced bone and kidney problems compared to current treatments. Via Buzzfeed News. Posted November 23,…
Starting antiretroviral drug therapy at birth seems to control the development of the HIV virus in children better than testing and waiting until the levels reach a pre-determined threshold. It also allows the child to take breaks from the toxic mix of drugs. ViaBusiness Recorder. – MedShadow Staff